| Record ID | ia:oralantidiabetic0119unse |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/oralantidiabetic0119unse/oralantidiabetic0119unse_marc.xml |
| Download MARC binary | https://www.archive.org/download/oralantidiabetic0119unse/oralantidiabetic0119unse_meta.mrc |
LEADER: 01064pam 2200289 a 4500
001 95023697
003 DLC
005 19960315111657.2
008 950705s1996 gw a b 001 0 eng c
010 $a 95023697
020 $a3540589902 (Berlin : acid-free paper)
040 $aDNLM/DLC$cDLC$dDLC
050 00 $aQP905$b.H3 vol. 119$aRC661.A1
060 10 $aW1 HA51L v.119 1995$aWK 825 O63 1995
082 00 $a615/.1 s$a616.4/62061$220
245 00 $aOral antidiabetics /$ccontributors, H.J. Ahr ... [et al.] ; editors, Jochen Kuhlman and Walter Puls.
260 $aBerlin ;$aNew York :$bSpringer,$cc1996.
300 $axxxi, 732 p. :$bill. ;$c25 cm.
440 0 $aHandbook of experimental pharmacology ;$vv. 119
650 0 $aHypoglycemic agents.
650 0 $aNon-insulin-dependent diabetes$xChemotherapy.
650 12 $aHypoglycemic Agents$xpharmacology.
650 12 $aHypoglycemic Agents$xtherapeutic use.
650 22 $aDiabetes Mellitus, Non-Insulin-Dependent$xdrug therapy.
700 1 $aAhr, H. J.
700 1 $aKuhlmann, J.$q(Jochen)
700 1 $aPuls, Walter.